LoginGet started
Picture of Swedish Orphan Biovitrum AB (publ) logo

SOBI — Swedish Orphan Biovitrum AB (publ) Income Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareAdventurousLarge CapNeutral
Balance sheetIncome statementCashflow
Subscribe to view all data

Annual income statement for Swedish Orphan Biovitrum AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue14,24815,26115,52918,79022,123
Cost of Revenue
Gross Profit10,91312,03612,04514,37717,171
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses9,71510,44311,79614,97718,057
Operating Profit4,5334,8183,7333,8134,066
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes4,2474,2173,2953,3212,954
Provision for Income Taxes
Net Income After Taxes3,3053,2452,6792,6382,408
Net Income Before Extraordinary Items
Net Income3,3053,2452,6792,6382,408
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income3,3043,2452,6792,6382,409
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS11.49.438.7910.28.63
Dividends per Share